Healthequity Inc (HQY) Director Sells $1,250,019.40 in Stock

Healthequity Inc (NASDAQ:HQY) Director Frank Medici sold 15,596 shares of the company’s stock in a transaction on Tuesday, July 10th. The stock was sold at an average price of $80.15, for a total transaction of $1,250,019.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Healthequity traded up $0.21, hitting $79.96, on Thursday, MarketBeat reports. The company’s stock had a trading volume of 378,726 shares, compared to its average volume of 598,681. Healthequity Inc has a fifty-two week low of $40.21 and a fifty-two week high of $82.04. The company has a market capitalization of $4.94 billion, a PE ratio of 148.09, a price-to-earnings-growth ratio of 3.31 and a beta of 1.42.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Monday, June 4th. The company reported $0.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.09. Healthequity had a net margin of 22.91% and a return on equity of 13.47%. The business had revenue of $69.90 million for the quarter, compared to the consensus estimate of $68.81 million. During the same period in the prior year, the company posted $0.23 earnings per share. Healthequity’s revenue was up 26.2% compared to the same quarter last year. equities research analysts anticipate that Healthequity Inc will post 0.72 earnings per share for the current fiscal year.

Several equities analysts have commented on HQY shares. Zacks Investment Research downgraded shares of Healthequity from a “buy” rating to a “hold” rating in a report on Wednesday, March 28th. KeyCorp upped their price objective on shares of Healthequity from $62.00 to $66.00 and gave the company an “overweight” rating in a report on Tuesday, March 20th. JPMorgan Chase & Co. started coverage on shares of Healthequity in a report on Tuesday, April 24th. They issued an “overweight” rating and a $69.00 price objective on the stock. Oppenheimer upped their price objective on shares of Healthequity from $58.00 to $68.00 and gave the company an “outperform” rating in a report on Tuesday, March 20th. Finally, Bank of America started coverage on shares of Healthequity in a report on Wednesday, May 23rd. They issued a “buy” rating and a $83.00 price objective on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $77.00.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Cim LLC bought a new stake in Healthequity during the second quarter worth about $204,000. Brown Advisory Inc. bought a new stake in Healthequity during the first quarter worth about $29,553,000. Principal Financial Group Inc. lifted its position in Healthequity by 4.0% during the first quarter. Principal Financial Group Inc. now owns 445,219 shares of the company’s stock worth $26,953,000 after purchasing an additional 17,193 shares during the period. WINTON GROUP Ltd bought a new stake in Healthequity during the first quarter worth about $206,000. Finally, Catalyst Capital Advisors LLC lifted its position in Healthequity by 190.4% during the first quarter. Catalyst Capital Advisors LLC now owns 9,294 shares of the company’s stock worth $563,000 after purchasing an additional 6,094 shares during the period. 96.58% of the stock is owned by institutional investors and hedge funds.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply